Home Uncategorized FDA Kicks CBD to Congress, Creating Uncertainty, Unease, and Opportunity

FDA Kicks CBD to Congress, Creating Uncertainty, Unease, and Opportunity

122
0
SHARE

Last week, the U.S. Food and Drug Administration (FDA) announced that instead of approving CBD as a food or dietary supplement, it was recommending that “a new regulatory pathway for…

The post FDA Kicks CBD to Congress, Creating Uncertainty, Unease, and Opportunity appeared first on Cannabis Business Executive – Cannabis and Marijuana industry news.

See also  Minnesota’s legal marijuana sales projected to reach $1.5B by 2029

LEAVE A REPLY

Please enter your comment!
Please enter your name here